06/15/2010 05:12 am ET | Updated May 25, 2011

GE Ignored Omniscan Safety Advice And May Have Hid Evidence From FDA, Documents Show

GE Healthcare ignored the advice of its own safety experts to "proactively" restrict use of its imaging drug, Omniscan, after reports in Europe linked the drug to a potentially crippling disease, according to a newly unsealed order in a lawsuit against the company.

The recommendation came at a May 2006 meeting convened by the company's vice president for drug safety. But instead of immediately alerting doctors to stop using the drug in high-risk patients, GE spent the next year arguing that approach wasn't necessary, even as some government and radiological experts favored such a ban.

Read more on ProPublica